Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases… Read more
Haw Par Corporation Limited (HAWPF) - Net Assets
Latest net assets as of June 2025: $4.08 Billion USD
Based on the latest financial reports, Haw Par Corporation Limited (HAWPF) has net assets worth $4.08 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.21 Billion) and total liabilities ($125.21 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.08 Billion |
| % of Total Assets | 97.02% |
| Annual Growth Rate | 8.7% |
| 5-Year Change | 43.79% |
| 10-Year Change | 63.64% |
| Growth Volatility | 28.23 |
Haw Par Corporation Limited - Net Assets Trend (2001–2024)
This chart illustrates how Haw Par Corporation Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Haw Par Corporation Limited (2001–2024)
The table below shows the annual net assets of Haw Par Corporation Limited from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $4.15 Billion | +19.35% |
| 2023-12-31 | $3.48 Billion | -2.05% |
| 2022-12-31 | $3.55 Billion | +10.50% |
| 2021-12-31 | $3.21 Billion | +11.31% |
| 2020-12-31 | $2.89 Billion | -8.59% |
| 2019-12-31 | $3.16 Billion | +7.80% |
| 2018-12-31 | $2.93 Billion | -4.88% |
| 2017-12-31 | $3.08 Billion | +24.35% |
| 2016-12-31 | $2.48 Billion | -2.35% |
| 2015-12-31 | $2.54 Billion | -9.70% |
| 2014-12-31 | $2.81 Billion | +14.84% |
| 2013-12-31 | $2.44 Billion | +8.50% |
| 2012-12-31 | $2.25 Billion | +26.59% |
| 2011-12-31 | $1.78 Billion | -8.70% |
| 2010-12-31 | $1.95 Billion | +2.08% |
| 2009-12-31 | $1.91 Billion | +43.92% |
| 2008-12-31 | $1.33 Billion | -31.39% |
| 2007-12-31 | $1.93 Billion | +7.09% |
| 2006-12-31 | $1.81 Billion | +36.84% |
| 2005-12-31 | $1.32 Billion | +120.11% |
| 2004-12-31 | $599.61 Million | +6.27% |
| 2003-12-31 | $564.23 Million | -2.95% |
| 2002-12-31 | $581.38 Million | -4.59% |
| 2001-12-31 | $609.33 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Haw Par Corporation Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 157896300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.58 Billion | 38.06% |
| Common Stock | $268.91 Million | 6.48% |
| Other Components | $2.30 Billion | 55.46% |
| Total Equity | $4.15 Billion | 100.00% |
Haw Par Corporation Limited Competitors by Market Cap
The table below lists competitors of Haw Par Corporation Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ProAssurance Corporation
NYSE:PRA
|
$1.17 Billion |
|
Luoyang Longhua Heat Trans Energy
SHE:300263
|
$1.17 Billion |
|
Aperam PK
PINK:APEMY
|
$1.17 Billion |
|
Kfin Technologies Limited
NSE:KFINTECH
|
$1.17 Billion |
|
Shanghai M&G Stationery Inc
SHG:603899
|
$1.17 Billion |
|
GEK TERNA Holdings Real Estate Construction S.A
PINK:GKTRF
|
$1.17 Billion |
|
Vizsla Resources Corp
NYSE MKT:VZLA
|
$1.16 Billion |
|
Poongsan
KO:103140
|
$1.16 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Haw Par Corporation Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,476,003,000 to 4,148,534,000, a change of 672,531,000 (19.3%).
- Net income of 228,274,000 contributed positively to equity growth.
- Dividend payments of 88,547,000 reduced retained earnings.
- Other comprehensive income decreased equity by 1,767,709,000.
- Other factors increased equity by 2,300,513,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $228.27 Million | +5.5% |
| Dividends Paid | $88.55 Million | -2.13% |
| Other Comprehensive Income | $-1.77 Billion | -42.61% |
| Other Changes | $2.30 Billion | +55.45% |
| Total Change | $- | 19.35% |
Book Value vs Market Value Analysis
This analysis compares Haw Par Corporation Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.45x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.14x to 0.45x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $2.67 | $8.37 | x |
| 2002-12-31 | $2.46 | $8.37 | x |
| 2003-12-31 | $2.47 | $8.37 | x |
| 2004-12-31 | $2.62 | $8.37 | x |
| 2005-12-31 | $5.80 | $8.37 | x |
| 2006-12-31 | $7.88 | $8.37 | x |
| 2007-12-31 | $8.57 | $8.37 | x |
| 2008-12-31 | $6.08 | $8.37 | x |
| 2009-12-31 | $8.76 | $8.37 | x |
| 2010-12-31 | $8.93 | $8.37 | x |
| 2011-12-31 | $8.17 | $8.37 | x |
| 2012-12-31 | $10.32 | $8.37 | x |
| 2013-12-31 | $11.18 | $8.37 | x |
| 2014-12-31 | $12.82 | $8.37 | x |
| 2015-12-31 | $11.57 | $8.37 | x |
| 2016-12-31 | $11.29 | $8.37 | x |
| 2017-12-31 | $13.98 | $8.37 | x |
| 2018-12-31 | $13.26 | $8.37 | x |
| 2019-12-31 | $14.27 | $8.37 | x |
| 2020-12-31 | $13.04 | $8.37 | x |
| 2021-12-31 | $14.51 | $8.37 | x |
| 2022-12-31 | $16.03 | $8.37 | x |
| 2023-12-31 | $15.70 | $8.37 | x |
| 2024-12-31 | $18.74 | $8.37 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Haw Par Corporation Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.50%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 93.24%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.03x
- Recent ROE (5.50%) is below the historical average (5.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 5.46% | 25.10% | 0.15x | 1.41x | $-26.38 Million |
| 2002 | 3.29% | 17.25% | 0.14x | 1.38x | $-37.05 Million |
| 2003 | 8.89% | 50.02% | 0.14x | 1.25x | $-6.20 Million |
| 2004 | 12.35% | 64.61% | 0.18x | 1.08x | $13.96 Million |
| 2005 | 6.12% | 66.70% | 0.09x | 1.06x | $-50.98 Million |
| 2006 | 5.95% | 89.48% | 0.06x | 1.06x | $-72.83 Million |
| 2007 | 8.25% | 133.23% | 0.06x | 1.06x | $-33.75 Million |
| 2008 | 5.93% | 64.10% | 0.09x | 1.07x | $-53.74 Million |
| 2009 | 3.00% | 46.00% | 0.06x | 1.05x | $-133.24 Million |
| 2010 | 5.79% | 86.70% | 0.06x | 1.05x | $-81.68 Million |
| 2011 | 4.48% | 60.15% | 0.07x | 1.05x | $-98.19 Million |
| 2012 | 5.32% | 86.09% | 0.06x | 1.05x | $-105.36 Million |
| 2013 | 4.41% | 76.44% | 0.06x | 1.05x | $-136.55 Million |
| 2014 | 4.23% | 77.05% | 0.05x | 1.06x | $-161.92 Million |
| 2015 | 7.23% | 102.48% | 0.07x | 1.06x | $-70.24 Million |
| 2016 | 5.05% | 62.01% | 0.08x | 1.06x | $-122.51 Million |
| 2017 | 3.98% | 54.97% | 0.07x | 1.06x | $-185.37 Million |
| 2018 | 6.12% | 75.30% | 0.08x | 1.03x | $-113.74 Million |
| 2019 | 5.77% | 74.68% | 0.08x | 1.03x | $-133.44 Million |
| 2020 | 4.15% | 107.87% | 0.04x | 1.02x | $-168.74 Million |
| 2021 | 3.43% | 77.99% | 0.04x | 1.02x | $-211.04 Million |
| 2022 | 4.18% | 81.45% | 0.05x | 1.03x | $-206.56 Million |
| 2023 | 6.23% | 93.32% | 0.06x | 1.03x | $-131.03 Million |
| 2024 | 5.50% | 93.24% | 0.06x | 1.03x | $-186.58 Million |
Industry Comparison
This section compares Haw Par Corporation Limited's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $355,057,678,100
- Average return on equity (ROE) among peers: -0.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Haw Par Corporation Limited (HAWPF) | $4.08 Billion | 5.46% | 0.03x | $1.17 Billion |
| AbbVie Inc (ABBV) | $15.70 Billion | 26.61% | 0.35x | $387.90 Billion |
| Astellas Pharma Inc (ALPMF) | $1.46 Trillion | 8.50% | 0.60x | $16.93 Billion |
| Amgen Inc (AMGN) | $80.60 Million | 0.62% | 0.16x | $194.15 Billion |
| Amarin Corporation PLC (AMRN) | $24.15 Million | -158.05% | 0.75x | $303.32 Million |
| AstraZeneca PLC (AZN) | $14.91 Billion | 37.51% | 2.22x | $295.24 Billion |
| Bayer AG (BAYZF) | $20.80 Billion | 15.33% | 1.47x | $21.61 Billion |
| Biogen Inc (BIIB) | $6.43 Billion | 19.21% | 0.41x | $27.11 Billion |
| Bristol-Myers Squibb Company (BMY) | $4.75 Billion | 22.46% | 0.58x | $121.36 Billion |
| Chugai Pharmaceutical Co. Ltd (CHGCF) | $2.03 Trillion | 21.42% | 0.22x | $28.30 Billion |
| Cosmo Pharmaceuticals N.V (CMOPF) | $58.37 Million | 6.18% | 0.57x | $529.97 Million |